Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 01, 2026 07:00 ET | Source: Step Pharma

Step Pharma announces the appointment of Neil Gallagher as Non-Executive Director

Neil Gallagher, MD, PhD, joins with over 25 years clinical development experience, having contributed to multiple commercial therapeutics across haematology and oncologyHis appointment will strengthen...
July 01, 2026 07:00 ET | Source: INmune Bio, Inc.

INmune Bio Advances CORDStrom™ Platform Patent Application in the U.S. Following Favorable International Written Opinion

Secures Global Framework for Composition-of-Matter and Method-of-Treatment Claims Covering Lead Program Ebstrocel for Epidermolysis Bullosa and Next-Generation Engineered Modalities Extending to 2045 ...
July 01, 2026 07:00 ET | Source: Seer, Inc.

Seer Prevails in European Patent Opposition as U.S. ITC Opens Investigation into Nanomics

REDWOOD CITY, Calif., July 01, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a pioneer and trusted partner for deep, unbiased proteomic insights, today announced two significant developments...
July 01, 2026 07:00 ET | Source: Can-Fite BioPharma Ltd.

Can-Fite Phase 2a Pancreatic Cancer Study with Namodenoson Achieves Primary Safety Endpoint and Demonstrates Durable Survival Outcomes in Advanced Disease

Predominantly third-line pancreatic cancer patients demonstrated durable survival despite advanced disease; patient who received Namodenoson as second-line therapy remains alive more than 18 months ...
July 01, 2026 06:07 ET | Source: Urteste S.A.

Urteste S.A. Receives U.S. Patent for the Panuri Test

Urteste S.A. Receives U.S. Patent for the Panuri Test Gdansk, Poland – 01 July 2026 – Urteste S.A. (Warsaw Stock Exchange:...
July 01, 2026 04:00 ET | Source: Alvotech

Alvotech further strengthens liquidity by securing term loan facility of $75 million

$75 million additional term loan facility maturing December 31, 2027, led by GoldenTree Asset ManagementFollows recent $165m equity raise strengthening cash positionIncluding equity financing and...
July 01, 2026 04:00 ET | Source: Alvotech

Alvotech styrkir lausafjárstöðu sína enn frekar með aðgengi að 75 milljóna dala lánsfjármögnun

- Hópur fjárfesta undir forystu GoldenTree Asset Management veitir Alvotech viðbótarlán að fjárhæð 75 milljónir dala - Lánveiting kemur í kjölfar nýlegrar hlutafjáraukningar að andvirði 165 milljóna...
July 01, 2026 04:00 ET | Source: Alvotech

Alvotech further strengthens liquidity by securing term loan facility of $75 million

— $75 million additional term loan facility maturing December 31, 2027, led by GoldenTree Asset Management — Follows recent $165m equity raise strengthening cash position — Including equity...
July 01, 2026 02:00 ET | Source: Eurobio Scientific

Eurobio Scientific finalise l'acquisition de la division « Lab Products » de CareDX dédiée à la transplantation

EUROBIO SCIENTIFIC FINALISE L'ACQUISITION DE LA DIVISION « LAB PRODUCTS1 » DE CAREDX DÉDIÉE À LA TRANSPLANTATION Accélération du plan stratégique d’Eurobio visant à devenir un leader du diagnostic...
July 01, 2026 02:00 ET | Source: Eurobio Scientific

Eurobio Scientific finalizes the acquisition of CareDX’s transplant Lab Product division

EUROBIO SCIENTIFIC FINALIZES THE ACQUISITION OF CAREDX’s TRANSPLANT LAB PRODUCT DIVISION Acceleration of Eurobio’s strategic plan to become an in-vitro molecular diagnostics (“IVD”) leaderCreation...